SELICK HAROLD E

CIK 00012872334 companiesNEWARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001287233

Recent Transactions

50 trades

Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2026-01-09−14,299→ 0 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-01-09$4.21/sh+14,299→ 60,845 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-01-02+2,695→ 46,546 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2026-01-02+3,762→ 3,762 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-04-28$1.16/sh+10,725→ 43,851 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2025-04-28−10,725→ 0 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2025-01-02+6,584→ 6,584 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-01-02+5,130→ 33,126 total
Award
Molecular Templates, Inc.
Stock Option (right to buy)
2024-09-27+1,000→ 1,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-03-07−6,490→ 0 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-03-07$1.89/sh+6,490→ 27,996 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-01-02+25,700→ 25,700 total
Award
Molecular Templates, Inc.
Stock Option (right to buy)
2023-10-27+1,000→ 1,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2023-04-10$0.87/sh+6,196→ 21,506 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2023-04-10−6,196→ 0 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2023-01-16+30,000→ 30,000 total
Award
Molecular Templates, Inc.
Stock Option (right to buy)
2022-06-03+15,000→ 15,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2022-05-26+20,000→ 20,000 total
Award
Molecular Templates, Inc.
Stock Option (right to buy)
2021-06-03+15,000→ 15,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2021-05-27+18,000→ 18,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2020-05-28+15,000→ 15,000 total
Award
Molecular Templates, Inc.
Stock Option (right to buy)
2020-05-28+15,000→ 15,000 total
Purchase
Protagonist Therapeutics, Inc$PTGX
Common Stock
2020-03-12$6.70/sh+12,000→ 15,310 total
Award
PDL BIOPHARMA, INC.
Stock Option (right to buy)
2019-06-20$3.00/sh+126,050→ 126,050 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2019-06-07+12,000→ 12,000 total
Award
Molecular Templates, Inc.
Stock Option (right to buy)
2019-05-29+15,000→ 15,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2019-04-01$1.31/sh+3,310→ 3,310 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2019-04-01−3,310→ 0 total
Award
PDL BIOPHARMA, INC.
Common stock
2018-06-08$2.76/sh+54,348→ 256,828 total
Award
Molecular Templates, Inc.
Stock Option (right to buy)
2018-05-31+15,000→ 15,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2018-05-29+12,000→ 12,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2018-01-16+550→ 550 total
Disposition to Issuer
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2018-01-16−500→ 0 total
Disposition to Issuer
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2018-01-16−450→ 0 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2018-01-16+500→ 500 total
Disposition to Issuer
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2018-01-16−10,000→ 0 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2018-01-16+10,000→ 10,000 total
Disposition to Issuer
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2018-01-16−197→ 0 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2018-01-16+197→ 197 total
Disposition to Issuer
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2018-01-16−550→ 0 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2018-01-16+450→ 450 total
Award
Molecular Templates, Inc.
Stock Option (right to buy)
2017-10-09+25,000→ 25,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2017-07-13+10,000→ 10,000 total
Award
PDL BIOPHARMA, INC.
Common stock
2017-06-09$2.47/sh+60,729→ 202,480 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2017-05-25+12,000→ 12,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2016-09-13+24,000→ 24,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2016-06-09+7,500→ 7,500 total
Award
PDL BIOPHARMA, INC.
Common stock
2016-06-02$3.52/sh+71,023→ 141,751 total
Award
Molecular Templates, Inc.
Stock Option (right to buy)
2016-03-14+800,000→ 800,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2015-10-22+6,750→ 6,750 total

Companies

Recent Filings

Address

C/O PROTAGONIST THERAPEUTICS, INC. 7707 GATEWAY BLVD., SUITE 140

NEWARK, CA, 94560-1160

View on SEC.gov